Achieving Remission Maintenance in AML

2024 ESMO Annual Meeting Insights Hub
T

ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradigm

By 2024 ESMO Annual Meeting Insights Hub FEATURING Teresa Macarulla Mercade
By 2024 ESMO Annual Meeting Insights Hub FEATURING Teresa Macarulla Mercade
53 views
September 30, 2024
Comments 0
Login to view comments. Click here to Login
14:21

New

Secondary AML: Best Therapy Options

Weill Cornell Medicine Oncology & Hematology

P. Desai

106 views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

651 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

719 views
34:34

Current & Emerging Therapies for AML and MDS

Indy Hematology Review

R. Komrokji

112 views
11:35

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Vanderbilt University Medical Center (VUMC)

A. Jallouk

254 views
25:57

Managing Intensive-Chemotherapy Ineligible Patients With AML

Scripps Health

C. DiNardo

158 views
18:44

Current and Emerging Treatment Approaches for Patients With AML or M…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

132 views
14:19

Challenges in the Management of TP53-Mutated AML: Potential Strategi…

Talha Badar

450 views
22:26

Management of AML in Older Patients

XV Eurasian Hematology-Oncology Congress - EHOC 2024

F. Ravandi

199 views
24:31

Current Treatment Landscape in Myeloid Malignancies

Houston Methodist

S. Shah

57 views
13:23

Current Role of Maintenance Therapy in AML

Alice Mims

169 views
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

523 views
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

466 views
21:20

The Future Paradigm of HMA + Ven or Targeted Agents in AML: Sequenci…

Insights from 2023 ASH Annual Meeting

J. Watts

176 views
27:28

AML: Current Treatment Landscape and Key Recent Updates

UChicago Medicine

A. Patel

384 views
16:11

Experts Discuss the Use of Targeted Therapies in AML

MyCancerHaven

R. Vij, E. Wang

222 views
12:15

Using Transplant in Patients With p53 Mutant MDS or AML

Moffitt Cancer Center

H. Elmariah

328 views
38:10

Experts Discuss How to Approach Frontline Treatment of Unfit Patient…

MyCancerHaven

R. Vij, J. Yang

105 views
19:51

A 50-Year Personal Perspective on the Treatment of AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Schiffer

165 views
26:00

Oral Azacitidine in AML: Results from QUAZAR-AML-001 Trial

Jane Liesveld

230 views
11:17

State of the Art: Role of Maintenance Therapy in AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Z. Aziz

230 views
18:42

Key Updates in AML, MDS, & MF From ASH

Memorial Sloan Kettering Cancer Center

A. Goldberg

299 views
23:15

Is Post-HSCT Maintenance the SOC for AML?

Rush University Medical Center

M. Levis

302 views
20:33

The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML

SOHO Brazil 2024

J. Lancet

135 views
09:31

The Role of Hypomethylating Agent Maintenance in AML

Yale Cancer Center

R. Shallis

117 views
12:00

EHA 2024 Insights: QUAZAR AML-001 - Oral Azacitidine Maintenance in …

Insights from 2024 EHA Annual Meeting

M. Teresa Voso

87 views
08:58

Importance of AML Maintenance Therapy

Gautam Borthakur

201 views
21:31

Optimal Use of Targeted Therapy for the Elderly or Unfit AML Patient

Moffitt Cancer Center

O. Chan

109 views